Prophylactic and therapeutic HPV vaccines: current scenario and perspectives

Y Mo, J Ma, H Zhang, J Shen, J Chen… - Frontiers in cellular …, 2022 - frontiersin.org
Persistent human papillomavirus (HPV) infection is recognized as the main cause of cervical
cancer and other malignant cancers. Although early detection and treatment can be …

[HTML][HTML] Therapeutic vaccines for high-risk HPV-associated diseases

A Chabeda, RJR Yanez, R Lamprecht, AE Meyers… - Papillomavirus …, 2018 - Elsevier
Cancer is the second leading cause of death worldwide, and it is estimated that Human
papillomavirus (HPV) related cancers account for 5% of all human cancers. Current HPV …

[PDF][PDF] Knowledge, attitude and practices regarding HPV vaccination among medical and para medical in students, India a cross sectional study

K Swarnapriya, D Kavitha… - Asian Pac J Cancer …, 2015 - pdfs.semanticscholar.org
Background: High risk human papilloma virus (HPV) types 16 and 18 have been proven as
central causes of cervical cancer and safety and immunogenicity of HPV vaccines are …

Human papilloma virus: an unraveled enigma of universal burden of malignancies

I Khan, R Harshithkumar, A More, A Mukherjee - Pathogens, 2023 - mdpi.com
HPV, or Human Papilloma Virus, has been the primary causative agent of genital warts and
cervical cancer worldwide. It is a sexually transmitted infection mainly affecting women of …

Roles of human papillomaviruses and p16 in oral cancer

T Sritippho, P Chotjumlong… - Asian Pacific Journal of …, 2015 - journal.waocp.org
Head and neck cancer, including oral cancer, is the sixth most common cancer in humans
worldwide. Morethan 90% of oral cancers are of squamous cell carcinoma type. Recent …

Global human papilloma virus vaccine implementation: An update

S Sabeena, PV Bhat, V Kamath… - Journal of Obstetrics …, 2018 - Wiley Online Library
Human papillomavirus (HPV) infections continue to be one of the most common sexually
transmitted infections worldwide. The oncogenic potential of this virus was well established …

Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives

S Ausoni, P Boscolo-Rizzo, B Singh… - Cancer and Metastasis …, 2016 - Springer
Despite improvements in functional outcomes attributable to advances in radiotherapy,
chemotherapy, surgical techniques, and imaging techniques, survival in head and neck …

Current status and future prospects for human papillomavirus vaccines

HJ Kim, HJ Kim - Archives of pharmacal research, 2017 - Springer
Cervical cancer is the fourth most frequent cancer among women worldwide. Human
papillomaviruses (HPVs) cause almost all cervical cancers in low-income countries. Three …

Effects of long-term vitamin D supplementation on regression and metabolic status of cervical intraepithelial neoplasia: a randomized, double-blind, placebo …

Z Vahedpoor, M Jamilian, F Bahmani… - Hormones and …, 2017 - Springer
We are not aware of any study examining the effects of long term vitamin D administration on
regression and metabolic status of patients with cervical intraepithelial neoplasia grade 1 …

Recent progress in therapeutic treatments and screening strategies for the prevention and treatment of HPV-associated head and neck cancer

SN Whang, M Filippova, P Duerksen-Hughes - Viruses, 2015 - mdpi.com
The rise in human papillomavirus (HPV)-associated head and neck squamous cell
carcinoma (HNSCC) has elicited significant interest in the role of high-risk HPV in …